No earnings within 2 weeks of this transaction.
| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | Mar 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Shares |
| Direct/Indirect | Direct |
| Filing Date | Mar 19, 2026 |
| Shares Sold | 200,000 |
| Price per Share | $28.24 |
| Total Value | $5,648,000.00 |
| Shares Owned After | 1,647,546 |
| Derivative | No |
| Accession Number | 0001635088-26-000026 |
| Document | View SEC Filing |